http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2364210-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_339b2b0fb37c3298fa27af1f92cdffd2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6809 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6827 |
| filingDate | 2010-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c2070fae4bd05a03d368660702525d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfe4d5efc4865661bf96370b09188578 |
| publicationDate | 2012-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2364210-B2 |
| titleOfInvention | METHOD FOR THE DEAMBIGUATION OF THE ACETILANTE METABOLISM OF AN INDIVIDUAL. |
| abstract | The present invention falls within the field of personalized medicine. In particular, the present invention relates to a method for disambiguation of the acetylating metabolism of the NAT2 gene of an individual. This method is useful for the prediction of drug metabolism by a specific individual in order to minimize the risks of possible side effects caused by a particular drug. |
| priorityDate | 2010-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.